Tirzepatide is one of the newest and most effective options for medical weight loss, helping patients lose weight faster and more consistently than ever before
An examination of pharmacy- and medical-claims data from 2021 for 4,066 nondiabetic GLP-1 users with obesity found 53.7 percent discontinued use within 180 days, and 67.7 percent stopped within a year
Brand name GLP-1 weight loss medications like Zepbound and Wegovy are more accessible than ever
In STEP trials, patients taking a 7 mg dose of Rybelsus experienced an average of 8.9% weight loss over 68 weeks, compared to 1.8% in the placebo group
Health metrics such as blood pressure, blood sugar, triglycerides, and HDL cholesterol also remained at the improved levels achieved during the weekly injection phase
Maximum results usually occur after 4-6 months, though this varies significantly between individuals based on skin type and pigmentation levels